Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q125292987 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241120235835.0 | ||
| 008 | 241120nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q125292987 | ||
| 035 | ‡a (OCoLC)Q125292987 | ||
| 100 | 0 | ‡a Ying-Nai Wang ‡c researcher ‡9 en | |
| 670 | ‡a Author's A flow-proteometric platform for analyzing protein concentration | ||
| 670 | ‡a Author's A flow-proteometric platform for analyzing protein concentration (FAP): Proof of concept for quantification of PD-L1 protein in cells and tissues | ||
| 670 | ‡a Author's A novel ligand-receptor relationship between families of ribonucleases and receptor tyrosine kinases | ||
| 670 | ‡a Author's An essential role of PRMT1-mediated EGFR methylation in EGFR activation by ribonuclease 5 | ||
| 670 | ‡a Author's Analysis of Individual Signaling Complexes by mMAPS, a Flow-Proteometric System. | ||
| 670 | ‡a Author's Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer. | ||
| 670 | ‡a Author's Biochemical fractionation of membrane receptors in the nucleus. | ||
| 670 | ‡a Author's Caspase-independent cell death is involved in the negative effect of EGF receptor inhibitors on cisplatin in non-small cell lung cancer cells. | ||
| 670 | ‡a Author's COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport | ||
| 670 | ‡a Author's Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation | ||
| 670 | ‡a Author's Digital Receptor Occupancy Assay in Quantifying On- and Off-Target Binding Affinities of Therapeutic Antibodies | ||
| 670 | ‡a Author's Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer | ||
| 670 | ‡a Author's FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization | ||
| 670 | ‡a Author's Functional roles of the human ribonuclease A superfamily in RNA metabolism and membrane receptor biology | ||
| 670 | ‡a Author's High speed digital protein interaction analysis using microfluidic single molecule detection system | ||
| 670 | ‡a Author's Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation | ||
| 670 | ‡a Author's Juxtacrine signaling inhibits antitumor immunity by upregulating PD-L1 expression. | ||
| 670 | ‡a Author's MEASUREMENT of Protein 53 Diffusion Coefficient in Live HeLa Cells Using Raster Image Correlation Spectroscopy | ||
| 670 | ‡a Author's MEASUREMENT of Protein 53 Diffusion Coefficient in Live HeLa Cells Using Raster Image Correlation Spectroscopy (RICS). | ||
| 670 | ‡a Author's Membrane-bound trafficking regulates nuclear transport of integral epidermal growth factor receptor (EGFR) and ErbB-2. | ||
| 670 | ‡a Author's mMAPS: a flow-proteometric technique to analyze protein-protein interactions in individual signaling complexes | ||
| 670 | ‡a Author's MRNIP condensates promote DNA double-strand break sensing and end resection | ||
| 670 | ‡a Author's Non-canonical signaling mode of the epidermal growth factor receptor family | ||
| 670 | ‡a Author's Nuclear ErbB2 enhances translation and cell growth by activating transcription of ribosomal RNA genes | ||
| 670 | ‡a Author's Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells | ||
| 670 | ‡a Author's PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response | ||
| 670 | ‡a Author's Rapid detection of two-protein interaction with a single fluorophore by using a microfluidic device | ||
| 670 | ‡a Author's Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy | ||
| 670 | ‡a Author's Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma | ||
| 670 | ‡a Author's RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus | ||
| 670 | ‡a Author's The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis | ||
| 670 | ‡a Author's The suppression of MAD1 by AKT-mediated phosphorylation activates MAD1 target genes transcription. | ||
| 670 | ‡a Author's The translocon Sec61beta localized in the inner nuclear membrane transports membrane-embedded EGF receptor to the nucleus | ||
| 670 | ‡a Author's Tyrosine 370 phosphorylation of ATM positively regulates DNA damage response | ||
| 919 | ‡a analysisofindividualsignalingcomplexesbymmapsaflowproteometricsystem ‡A Analysis of Individual Signaling Complexes by mMAPS, a Flow-Proteometric System. ‡9 1 | ||
| 919 | ‡a copimediatedretrogradetraffickingfromthegolgitotheerregulatesegfrnucleartransport ‡A COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport ‡9 1 | ||
| 919 | ‡a crosstalkbetweenarg1175methylationandtyr1173phosphorylationnegativelymodulatesegfrmediatederkactivation ‡A Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation ‡9 1 | ||
| 919 | ‡a digitalreceptoroccupancyassayinquantifyingonandofftargetbindingaffinitiesoftherapeuticantibodies ‡A Digital Receptor Occupancy Assay in Quantifying On- and Off-Target Binding Affinities of Therapeutic Antibodies ‡9 1 | ||
| 919 | ‡a ephrinreceptora10monoclonalantibodiesandthederivedchimericantigenreceptortcellsexertanantitumorresponseinmousemodelsoftriplenegativebreastcancer ‡A Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer ‡9 1 | ||
| 919 | ‡a foxo3adependentmechanismofe1ainducedchemosensitization ‡A FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization ‡9 1 | ||
| 919 | ‡a functionalrolesofthehumanribonucleaseasuperfamilyinrnametabolismandmembranereceptorbiology ‡A Functional roles of the human ribonuclease A superfamily in RNA metabolism and membrane receptor biology ‡9 1 | ||
| 919 | ‡a highspeeddigitalproteininteractionanalysisusingmicrofluidicsinglemoleculedetectionsystem ‡A High speed digital protein interaction analysis using microfluidic single molecule detection system ‡9 1 | ||
| 919 | ‡a humanribonuclease1servesasasecretoryligandofephrina4receptorandinducesbreasttumorinitiation ‡A Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation ‡9 1 | ||
| 919 | ‡a juxtacrinesignalinginhibitsantitumorimmunitybyupregulatingpdl1expression ‡A Juxtacrine signaling inhibits antitumor immunity by upregulating PD-L1 expression. ‡9 1 | ||
| 919 | ‡a measurementofprotein53diffusioncoefficientinlivehelacellsusingrasterimagecorrelationspectroscopy ‡A MEASUREMENT of Protein 53 Diffusion Coefficient in Live HeLa Cells Using Raster Image Correlation Spectroscopy ‡9 1 | ||
| 919 | ‡a measurementofprotein53diffusioncoefficientinlivehelacellsusingrasterimagecorrelationspectroscopyrics ‡A MEASUREMENT of Protein 53 Diffusion Coefficient in Live HeLa Cells Using Raster Image Correlation Spectroscopy (RICS). ‡9 1 | ||
| 919 | ‡a removalofnlinkedglycosylationenhancespdl1detectionandpredictsantipd1pdl1therapeuticefficacy ‡A Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy ‡9 1 | ||
| 919 | ‡a ribonuclease7drivenactivationofros1isapotentialtherapeutictargetinhepatocellularcarcinoma ‡A Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma ‡9 1 | ||
| 919 | ‡a rnahelicaseaisadnabindingpartnerforegfrmediatedtranscriptionalactivationinthenucleus ‡A RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus ‡9 1 | ||
| 919 | ‡a membraneboundtraffickingregulatesnucleartransportofintegralepidermalgrowthfactorreceptoregfranderbb2 ‡A Membrane-bound trafficking regulates nuclear transport of integral epidermal growth factor receptor (EGFR) and ErbB-2. ‡9 1 | ||
| 919 | ‡a mmapsaflowproteometrictechniquetoanalyzeproteinproteininteractionsinindividualsignalingcomplexes ‡A mMAPS: a flow-proteometric technique to analyze protein-protein interactions in individual signaling complexes ‡9 1 | ||
| 919 | ‡a mrnipcondensatespromotednadoublestrandbreaksensingandendresection ‡A MRNIP condensates promote DNA double-strand break sensing and end resection ‡9 1 | ||
| 919 | ‡a noncanonicalsignalingmodeoftheepidermalgrowthfactorreceptorfamily ‡A Non-canonical signaling mode of the epidermal growth factor receptor family ‡9 1 | ||
| 919 | ‡a nuclearerbb2enhancestranslationandcellgrowthbyactivatingtranscriptionofribosomalrnagenes ‡A Nuclear ErbB2 enhances translation and cell growth by activating transcription of ribosomal RNA genes ‡9 1 | ||
| 919 | ‡a nucleartranslocationofepidermalgrowthfactorreceptorbyaktdependentphosphorylationenhancesbreastcancerresistantproteinexpressioningefitinibresistantcells ‡A Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells ‡9 1 | ||
| 919 | ‡a prmt1mediatedmethylationoftheegfreceptorregulatessignalingandcetuximabresponse ‡A PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response ‡9 1 | ||
| 919 | ‡a rapiddetectionof2proteininteractionwithasinglefluorophorebyusingamicrofluidicdevice ‡A Rapid detection of two-protein interaction with a single fluorophore by using a microfluidic device ‡9 1 | ||
| 919 | ‡a impactofpdl1nlinkedglycosylationoncancertherapyandclinicaldiagnosis ‡A The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis ‡9 1 | ||
| 919 | ‡a suppressionofmad1byaktmediatedphosphorylationactivatesmad1targetgenestranscription ‡A The suppression of MAD1 by AKT-mediated phosphorylation activates MAD1 target genes transcription. ‡9 1 | ||
| 919 | ‡a transloconsec61betalocalizedintheinnernuclearmembranetransportsmembraneembeddedegfreceptortothenucleus ‡A The translocon Sec61beta localized in the inner nuclear membrane transports membrane-embedded EGF receptor to the nucleus ‡9 1 | ||
| 919 | ‡a tyrosine370phosphorylationofatmpositivelyregulatesdnadamageresponse ‡A Tyrosine 370 phosphorylation of ATM positively regulates DNA damage response ‡9 1 | ||
| 919 | ‡a essentialroleofprmt1mediatedegfrmethylationinegfractivationbyribonuclease5 ‡A An essential role of PRMT1-mediated EGFR methylation in EGFR activation by ribonuclease 5 ‡9 1 | ||
| 919 | ‡a novelligandreceptorrelationshipbetweenfamiliesofribonucleasesandreceptortyrosinekinases ‡A A novel ligand-receptor relationship between families of ribonucleases and receptor tyrosine kinases ‡9 1 | ||
| 919 | ‡a flowproteometricplatformforanalyzingproteinconcentrationfapproofofconceptforquantificationofpdl1proteinincellsandtissues ‡A A flow-proteometric platform for analyzing protein concentration (FAP): Proof of concept for quantification of PD-L1 protein in cells and tissues ‡9 1 | ||
| 919 | ‡a flowproteometricplatformforanalyzingproteinconcentration ‡A A flow-proteometric platform for analyzing protein concentration ‡9 1 | ||
| 919 | ‡a caspaseindependentcelldeathisinvolvedinthenegativeeffectofegfreceptorinhibitorsoncisplatininnonsmallcelllungcancercells ‡A Caspase-independent cell death is involved in the negative effect of EGF receptor inhibitors on cisplatin in non-small cell lung cancer cells. ‡9 1 | ||
| 919 | ‡a biochemicalfractionationofmembranereceptorsinthenucleus ‡A Biochemical fractionation of membrane receptors in the nucleus. ‡9 1 | ||
| 919 | ‡a angiogeninribonuclease5isanegfrligandandaserumbiomarkerforerlotinibsensitivityinpancreaticcancer ‡A Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer. ‡9 1 | ||
| 996 | ‡2 DNB|1228989184 | ||
| 996 | ‡2 LC|no2020000042 | ||
| 996 | ‡2 DNB|1284313719 | ||
| 996 | ‡2 SUDOC|197649793 | ||
| 996 | ‡2 ISNI|0000000381823211 | ||
| 996 | ‡2 LC|n 2017002298 | ||
| 996 | ‡2 ISNI|0000000382154013 | ||
| 996 | ‡2 DNB|1294353926 | ||
| 996 | ‡2 CAOONL|ncf11010848 | ||
| 996 | ‡2 PLWABN|9811769723105606 | ||
| 996 | ‡2 SUDOC|225458586 | ||
| 996 | ‡2 ISNI|0000000419504938 | ||
| 996 | ‡2 RERO|A011229893 | ||
| 996 | ‡2 PLWABN|9811772643705606 | ||
| 996 | ‡2 RERO|A016412813 | ||
| 996 | ‡2 ISNI|0000000084213927 | ||
| 996 | ‡2 PLWABN|9810556605705606 | ||
| 996 | ‡2 J9U|987007423048605171 | ||
| 996 | ‡2 DNB|1116348470 | ||
| 996 | ‡2 NSK|000744170 | ||
| 996 | ‡2 ISNI|0000000117358277 | ||
| 996 | ‡2 SUDOC|199215383 | ||
| 996 | ‡2 ISNI|000000007811333X | ||
| 996 | ‡2 NSK|000491409 | ||
| 996 | ‡2 ISNI|0000000064181681 | ||
| 996 | ‡2 LC|n 82053586 | ||
| 996 | ‡2 CYT|AC000639740 | ||
| 996 | ‡2 DNB|122561414 | ||
| 996 | ‡2 SUDOC|066971519 | ||
| 996 | ‡2 DNB|1058343815 | ||
| 996 | ‡2 LC|n 87910505 | ||
| 996 | ‡2 LC|n 96061111 | ||
| 996 | ‡2 ISNI|0000000083009270 | ||
| 996 | ‡2 DNB|1305817214 | ||
| 996 | ‡2 DNB|1256955388 | ||
| 996 | ‡2 BNF|17122253 | ||
| 996 | ‡2 DNB|1021936561 | ||
| 996 | ‡2 ISNI|0000000072889786 | ||
| 996 | ‡2 W2Z|8014740 | ||
| 996 | ‡2 DNB|1140651730 | ||
| 996 | ‡2 DNB|1169145639 | ||
| 996 | ‡2 BIBSYS|8014740 | ||
| 996 | ‡2 SUDOC|112854605 | ||
| 996 | ‡2 DNB|131966626 | ||
| 996 | ‡2 NII|DA11666540 | ||
| 996 | ‡2 LC|nb2005017557 | ||
| 996 | ‡2 PLWABN|9814026572505606 | ||
| 996 | ‡2 LC|n 2024035236 | ||
| 996 | ‡2 DNB|1282066676 | ||
| 996 | ‡2 ISNI|0000000381993552 | ||
| 996 | ‡2 J9U|987007385861605171 | ||
| 996 | ‡2 ISNI|0000000051169253 | ||
| 996 | ‡2 LC|n 2010038119 | ||
| 996 | ‡2 BNF|14534463 | ||
| 996 | ‡2 LC|n 2013185837 | ||
| 996 | ‡2 NTA|271553707 | ||
| 996 | ‡2 DNB|1218025166 | ||
| 996 | ‡2 ISNI|0000000063559750 | ||
| 996 | ‡2 DNB|1277888515 | ||
| 996 | ‡2 CYT|AC000642158 | ||
| 996 | ‡2 SUDOC|16711753X | ||
| 996 | ‡2 LC|no 95045069 | ||
| 996 | ‡2 NUKAT|n 2021020761 | ||
| 996 | ‡2 DNB|1027554016 | ||
| 996 | ‡2 LC|no2020111123 | ||
| 996 | ‡2 DNB|132433195X | ||
| 996 | ‡2 ISNI|0000000119738572 | ||
| 996 | ‡2 SUDOC|228355583 | ||
| 996 | ‡2 CYT|AC000210409 | ||
| 996 | ‡2 ISNI|000000049573169X | ||
| 996 | ‡2 DNB|1313383376 | ||
| 996 | ‡2 J9U|987007315980005171 | ||
| 996 | ‡2 LC|n 85220755 | ||
| 996 | ‡2 LC|n 85290732 | ||
| 996 | ‡2 ISNI|0000000083401336 | ||
| 996 | ‡2 NDL|00622078 | ||
| 996 | ‡2 ISNI|0000000383417305 | ||
| 996 | ‡2 DNB|1156741904 | ||
| 996 | ‡2 NSK|000461453 | ||
| 996 | ‡2 LC|n 78055386 | ||
| 996 | ‡2 BNF|14420666 | ||
| 996 | ‡2 PLWABN|9811566399305606 | ||
| 996 | ‡2 DNB|1334893349 | ||
| 996 | ‡2 LC|n 87140441 | ||
| 996 | ‡2 ISNI|0000000115000466 | ||
| 996 | ‡2 BNF|16578299 | ||
| 996 | ‡2 NYNYRILM|233075 | ||
| 996 | ‡2 NKC|jcu2011668708 | ||
| 996 | ‡2 ISNI|0000000500998568 | ||
| 996 | ‡2 ISNI|0000000034198589 | ||
| 996 | ‡2 NUKAT|n 2011076877 | ||
| 996 | ‡2 LC|nr 90027381 | ||
| 996 | ‡2 DNB|13293793X | ||
| 996 | ‡2 LC|no2008036637 | ||
| 996 | ‡2 LC|no2017010340 | ||
| 996 | ‡2 DNB|142704547 | ||
| 996 | ‡2 ISNI|0000000055085487 | ||
| 996 | ‡2 LC|no2008036638 | ||
| 996 | ‡2 LC|nr 94002430 | ||
| 996 | ‡2 ISNI|0000000383148467 | ||
| 996 | ‡2 ISNI|0000000123207600 | ||
| 996 | ‡2 DNB|1249803926 | ||
| 996 | ‡2 LC|no2019009464 | ||
| 996 | ‡2 J9U|987007370953405171 | ||
| 996 | ‡2 NTA|357940121 | ||
| 996 | ‡2 LC|nr 91010950 | ||
| 996 | ‡2 ISNI|0000000388081230 | ||
| 996 | ‡2 LC|n 85245444 | ||
| 996 | ‡2 NTA|438699432 | ||
| 996 | ‡2 LC|n 87921087 | ||
| 996 | ‡2 DNB|1059125005 | ||
| 996 | ‡2 DNB|140953310 | ||
| 996 | ‡2 PLWABN|9812854303105606 | ||
| 996 | ‡2 LC|n 83329341 | ||
| 996 | ‡2 NII|DA17897648 | ||
| 996 | ‡2 SUDOC|203358139 | ||
| 996 | ‡2 DNB|1272193489 | ||
| 996 | ‡2 LC|n 85331694 | ||
| 996 | ‡2 SUDOC|161278086 | ||
| 996 | ‡2 DNB|125792328 | ||
| 996 | ‡2 DNB|1149707704 | ||
| 996 | ‡2 NTA|154177776 | ||
| 996 | ‡2 DNB|1337440051 | ||
| 996 | ‡2 BIBSYS|14006582 | ||
| 996 | ‡2 ISNI|0000000043872758 | ||
| 996 | ‡2 DNB|1112658564 | ||
| 996 | ‡2 DNB|112598127X | ||
| 996 | ‡2 NTA|417377142 | ||
| 996 | ‡2 LC|nr 91017985 | ||
| 996 | ‡2 ISNI|0000000052102560 | ||
| 996 | ‡2 ISNI|0000000079978482 | ||
| 996 | ‡2 DNB|105080144X | ||
| 996 | ‡2 CYT|AC000642051 | ||
| 996 | ‡2 SUDOC|144733617 | ||
| 996 | ‡2 LC|n 84043280 | ||
| 996 | ‡2 LC|no2007026334 | ||
| 996 | ‡2 DNB|1074551303 | ||
| 996 | ‡2 SUDOC|204375894 | ||
| 996 | ‡2 CYT|AC000210563 | ||
| 996 | ‡2 ISNI|0000000038635416 | ||
| 996 | ‡2 ISNI|0000000382059120 | ||
| 996 | ‡2 ISNI|0000000382662093 | ||
| 996 | ‡2 LC|n 2016035042 | ||
| 996 | ‡2 DNB|1044952725 | ||
| 996 | ‡2 NII|DA11926969 | ||
| 996 | ‡2 CYT|AC000635525 | ||
| 996 | ‡2 LC|no2023102251 | ||
| 996 | ‡2 LC|no 95004494 | ||
| 996 | ‡2 RERO|A000175187 | ||
| 996 | ‡2 LC|n 88047030 | ||
| 996 | ‡2 LC|no2010162940 | ||
| 996 | ‡2 CYT|AC000642228 | ||
| 996 | ‡2 CYT|AC000007541 | ||
| 996 | ‡2 LC|n 85345150 | ||
| 996 | ‡2 CAOONL|ncf11341397 | ||
| 996 | ‡2 ISNI|0000000001024558 | ||
| 996 | ‡2 CYT|AC000431061 | ||
| 996 | ‡2 NTA|439922674 | ||
| 996 | ‡2 ISNI|0000000061585226 | ||
| 996 | ‡2 SUDOC|111303656 | ||
| 996 | ‡2 ISNI|000000006343507X | ||
| 996 | ‡2 NTA|34586722X | ||
| 996 | ‡2 LC|n 79118819 | ||
| 996 | ‡2 LC|nr 94004574 | ||
| 996 | ‡2 ISNI|0000000497693332 | ||
| 996 | ‡2 DNB|101175357X | ||
| 996 | ‡2 ISNI|0000000064058835 | ||
| 996 | ‡2 NTA|071984771 | ||
| 996 | ‡2 ISNI|0000000063787112 | ||
| 996 | ‡2 DNB|1117115941 | ||
| 996 | ‡2 SUDOC|188108483 | ||
| 996 | ‡2 PLWABN|9812807237105606 | ||
| 996 | ‡2 LC|n 2021067755 | ||
| 996 | ‡2 LC|no2016128854 | ||
| 996 | ‡2 LC|n 78075187 | ||
| 996 | ‡2 DNB|1021091707 | ||
| 996 | ‡2 SUDOC|231618387 | ||
| 996 | ‡2 NTA|340415975 | ||
| 996 | ‡2 ISNI|0000000078010488 | ||
| 996 | ‡2 SELIBR|405818 | ||
| 996 | ‡2 ISNI|000000009910714X | ||
| 996 | ‡2 ISNI|0000000453084201 | ||
| 996 | ‡2 LC|no2015012366 | ||
| 996 | ‡2 LC|no 97021789 | ||
| 996 | ‡2 LC|no2007023617 | ||
| 996 | ‡2 LC|n 88263117 | ||
| 996 | ‡2 DNB|1207887846 | ||
| 996 | ‡2 DNB|1043946098 | ||
| 996 | ‡2 DNB|173861970 | ||
| 996 | ‡2 ISNI|0000000118058313 | ||
| 996 | ‡2 LC|no2022145572 | ||
| 996 | ‡2 LIH|LNB:B5_j_M;=BU | ||
| 996 | ‡2 LC|no2005096257 | ||
| 996 | ‡2 DNB|1263641350 | ||
| 996 | ‡2 LC|no2023032790 | ||
| 996 | ‡2 DNB|1169356354 | ||
| 996 | ‡2 SUDOC|22486906X | ||
| 996 | ‡2 DNB|1235624242 | ||
| 996 | ‡2 DBC|87097969817025 | ||
| 996 | ‡2 ISNI|0000000075388661 | ||
| 996 | ‡2 NDL|00481890 | ||
| 996 | ‡2 BNC|981058525301006706 | ||
| 996 | ‡2 ISNI|000000039938347X | ||
| 996 | ‡2 ISNI|0000000064161576 | ||
| 996 | ‡2 J9U|987007585316305171 | ||
| 996 | ‡2 DNB|143772511 | ||
| 996 | ‡2 LC|nr 00003879 | ||
| 996 | ‡2 BNF|16757206 | ||
| 996 | ‡2 NUKAT|n 2004020726 | ||
| 996 | ‡2 NSK|000736560 | ||
| 996 | ‡2 DNB|1221088807 | ||
| 996 | ‡2 LC|no2018146027 | ||
| 996 | ‡2 ISNI|0000000063669415 | ||
| 996 | ‡2 DNB|1283679086 | ||
| 996 | ‡2 PLWABN|9812843085105606 | ||
| 996 | ‡2 CYT|AC000585314 | ||
| 996 | ‡2 ISNI|0000000083246831 | ||
| 996 | ‡2 ISNI|0000000016882651 | ||
| 996 | ‡2 DNB|1231388838 | ||
| 996 | ‡2 LC|no2021123681 | ||
| 996 | ‡2 DNB|173432263 | ||
| 996 | ‡2 LC|no2021123682 | ||
| 996 | ‡2 LC|nr 98000118 | ||
| 996 | ‡2 ISNI|0000000048435784 | ||
| 996 | ‡2 CYT|AC000654323 | ||
| 996 | ‡2 LC|nr 91026008 | ||
| 996 | ‡2 ISNI|000000041942580X | ||
| 996 | ‡2 CYT|AC000659535 | ||
| 996 | ‡2 CYT|AC000634580 | ||
| 996 | ‡2 PLWABN|9812033286105606 | ||
| 996 | ‡2 LC|no2008150139 | ||
| 996 | ‡2 SUDOC|156786397 | ||
| 996 | ‡2 CAOONL|ncf10327315 | ||
| 996 | ‡2 DNB|1205171525 | ||
| 996 | ‡2 RERO|A020186071 | ||
| 996 | ‡2 LC|no2009025942 | ||
| 996 | ‡2 LC|n 2011077689 | ||
| 996 | ‡2 NII|DA07469182 | ||
| 996 | ‡2 JPG|500128019 | ||
| 996 | ‡2 DNB|1331206928 | ||
| 996 | ‡2 DNB|1330951611 | ||
| 996 | ‡2 BNF|16652296 | ||
| 996 | ‡2 BIBSYS|8004847 | ||
| 996 | ‡2 SUDOC|229632955 | ||
| 996 | ‡2 ISNI|0000000382436619 | ||
| 996 | ‡2 NTA|157518787 | ||
| 996 | ‡2 DNB|1034963244 | ||
| 996 | ‡2 ISNI|000000005452509X | ||
| 996 | ‡2 LC|n 79066195 | ||
| 996 | ‡2 LC|n 88016460 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
